Clinical trial
Phase II Study of Dietary Cholesterol for Smith-Lemli-Opitz Syndrome
NCT00004347 · National Center for Research Resources (NCRR), NIH · Unknown status
Key facts
| NCT number | NCT00004347 |
|---|---|
| Title | Phase II Study of Dietary Cholesterol for Smith-Lemli-Opitz Syndrome |
| Official title | The Effects of Dietary Cholesterol in the Smith-Lemli-Opitz Syndrome |
| Lead sponsor | National Center for Research Resources (NCRR), NIH |
| Collaborators | Oregon Health and Science University |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Smith-Lemli-Opitz Syndrome |
| Intervention type | Behavioral |
| Interventions | diet |
| Enrollment | 5 |
| Start date | Nov 1, 1995 |
| First posted | Oct 19, 1999 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: